2021
DOI: 10.1016/j.oraloncology.2021.105504
|View full text |Cite
|
Sign up to set email alerts
|

An overview of the current clinical status of optical imaging in head and neck cancer with a focus on Narrow Band imaging and fluorescence optical imaging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
21
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 19 publications
(21 citation statements)
references
References 89 publications
0
21
0
Order By: Relevance
“…Other optical techniques, such as narrow-band imaging (NBI), have shown promising results in tumor diagnosis in the upper aerodigestive tract with an overall sensitivity and specificity of 89% and 96% [ 34 ]. This technique differs fundamentally from CLE.…”
Section: Discussionmentioning
confidence: 99%
“…Other optical techniques, such as narrow-band imaging (NBI), have shown promising results in tumor diagnosis in the upper aerodigestive tract with an overall sensitivity and specificity of 89% and 96% [ 34 ]. This technique differs fundamentally from CLE.…”
Section: Discussionmentioning
confidence: 99%
“…However, identifying specific biomarkers for OSCC imaging is urgently required. Previous studies on OSCC imaging have mainly focused on EGFR, 41 PARP1 42 and c‐Met 43 as imaging biomarkers 13 . However, tumors are heterogeneous and the current understanding of OSCC imaging biomarkers is unclear; hence, it is necessary to investigate more promising potential imaging biomarkers 44 .…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies on OSCC imaging have mainly focused on EGFR, 41 PARP1 42 and c-Met 43 as imaging biomarkers. 13 However, tumors are heterogeneous and the current understanding of OSCC imaging biomarkers is unclear; hence, it is necessary to investigate more promising potential imaging biomarkers. 44 In the present study, GLUT1 was identified as a new potential biomarker for OSCCtargeted imaging.…”
Section: Biosafety Of Wzb117-ir820mentioning
confidence: 99%
See 2 more Smart Citations